For Immediate Release
April 17, 2007
Another Wachovia Securities Executive Attacked by ALF in Portland
Firm Invests in Huntingdon Life Sciences’ Customer GlaxoSmithKline
Portland: In an anonymous communique received by the North American Animal Liberation Press Office, Animal Liberation Front (ALF) activists have claimed an attack on a second Wachovia Securities executive in one month’s time for his company’s role in supporting animal testing. Wachovia invests heavily in GlaxoSmithKline, one of the largest customers of Huntingdon Life Sciences (HLS), Europe’s largest contract animal testing company. According to the communique, activists spray-painted the shiny SUV of Wachovia Vice-president Kevin Singer during the early hours of April tenth.
Huntingdon Life Sciences has been exposed in six consecutive undercover investigations abusing animals, violating animal welfare regulations and killing 500 dogs, primates and other animals every day testing such products as oven cleaners and pesticides. Before losing their NYSE listing in September, the company had lost their listing on the London Stock Exchange over four years ago, after a sustained campaign by activists who exposed atrocities occurring inside HLS facilities.
The communique reads in part:
The Animal Liberation Front has kept it’s promise by continuing it’s campaign against Wachovia Securities for that company’s continued financial relationship with HLS customer GlaxcoSmithKline. On the night of April 10th the ALF visited 3425 North East 19th Ave., Portland, Oregon, the home of Kevin Singer, vice president of Wealth Management of Wachovia Securities. Your shiny new SUV isn’t too shiny any more after we left it spray-painted with slogans and paint-stripped.
Dozens of investment, insurance and banking firms, including Charles Schwab and Co.,TD Waterhouse and Marsh Inc. have ceased trading in HLS shares (OTC: LSRI) or doing business with HLS after being targeted by activists and learning of the company’s involvement with animal cruelty.